Antares Pharma (ATRS) Stock: Headed Up On Agreement With Pfizer (PFE)

Antares Pharma Inc (NASDAQ: ATRS) is having an overwhelmingly strong start to the trading session this morning, and for good reason. The company announced that it has entered into a collaboration agreement with Pfizer Inc. (NYSE: PFE) surrounding the development of a combination drug. Today, we’ll talk about: The collaboration; what we’re seeing from ATRS … Read more

Antares Pharma (ATRS) Stock: Heading Up On Regulatory News

Antares Pharma Inc (NASDAQ: ATRS) is headed up in the pre-market hours this morning after announcing a regulatory update surrounding XYOSTEDTM (testosterone enanthate subcutaneous injection). Of course, the update was a positive one, leading to excitement-fueled gains as the stock makes it clear into the green in the pre-market hours. Today, we’ll talk about: The … Read more

AMAG Pharmaceuticals (AMAG) Stock: Gaining Big On FDA Approval

AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is having an overwhelmingly strong day in the market today, and for good reason. In a press release issued early this morning, Antares Pharma, Inc. (NASDAQ: ATRS) announced that the FDA has approved a New Drug Application or NDA, that includes an AMAG Pharmaceuticals treatment. Today, we’ll talk about the approval, what … Read more

Antares Pharma (ATRS) Stock: Gaining Big On FDA Approval

Antares Pharma Inc (NASDAQ: ATRS) is having an overwhelmingly strong day in the market today, and for good reason. The company announced that the United States Food and Drug Administration has approved a New Drug Application they submitted, leading to excitement among investors and sending the stock screaming for the top. Today, we’ll talk about the … Read more